Charles River Laboratories International (CRL) Interest Coverage Ratio (2009 - 2026)
Charles River Laboratories International (CRL) posted Interest Coverage Ratio of 3.95 for Q2 2026, down 11.87% on a QoQ basis from 4.48 in Q1 2026, and up 18.26% year-over-year from 3.34 in Q2 2025.
Analysis
Charles River Laboratories International (CRL) Interest Coverage Ratio (2009 - 2026) Analysis & Trends
Charles River Laboratories International has reported Interest Coverage Ratio for 18 years, with the latest figure at 3.95 in Q2 2026.
- On a quarterly basis, Interest Coverage Ratio rose 18.26% year-over-year to 3.95 in Q2 2026; TTM through Jun 2026 was 0.85, a 20.72% decrease from a year earlier, with the FY2025 full-year figure at 0.24, down 86.94% from the prior year.
- Interest Coverage Ratio was 3.95 for Q2 2026 at Charles River Laboratories International, down from 4.48 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 50.61 in Q2 2022, with the low at 11.92 in Q4 2025.
- Average Interest Coverage Ratio over 5 years is 6.47, with a median of 4.49 recorded in 2023.
- The sharpest annual moves came in 2022 and 2024: Interest Coverage Ratio jumped 495.7% in 2022, then tumbled 249.88% in 2024.
- Over 5 years, Interest Coverage Ratio stood at 4.71 in 2022, then declined by 15.87% to 3.96 in 2023, then slumped by 249.88% to 5.94 in 2024, then sank by 100.73% to 11.92 in 2025, then jumped by 133.15% to 3.95 in 2026.
- The last three Interest Coverage Ratio figures came in at 3.95 (Q2 2026), 4.48 (Q1 2026), and 11.92 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 2.57 |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 2.83 |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 3.95 |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -689.75 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 3.95 |
| Mar 28, 2026 | 4.48 |
| Dec 27, 2025 | -11.92 |
| Sep 27, 2025 | 5.27 |
| Jun 28, 2025 | 3.34 |
| Mar 29, 2025 | 2.68 |
| Dec 28, 2024 | -5.94 |
| Sep 28, 2024 | 3.88 |
| Jun 29, 2024 | 4.63 |
| Mar 30, 2024 | 3.60 |
| Dec 30, 2023 | 3.96 |
| Sep 30, 2023 | 4.49 |
| Jul 1, 2023 | 4.71 |
| Apr 1, 2023 | 4.88 |
| Dec 31, 2022 | 4.71 |
| Sep 24, 2022 | 13.27 |
| Jun 25, 2022 | 50.61 |
| Mar 26, 2022 | 15.77 |
| Dec 25, 2021 | 14.97 |
| Sep 25, 2021 | 9.47 |